Union Will Better Inform Spine Surgery
CARLSBAD, Calif., June 07, 2021 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (Nasdaq: ATEC), is a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery. Centered on a singular vision to better inform surgery, ATEC today welcomes the EOS imaging team in a combination forged to improve the predictability of the patient experience in spine from diagnosis through follow up.
“I am thrilled to officially welcome EOS’ teams to the ATEC family,” stated Pat Miles, Chairman and Chief Executive Officer. “Uniting EOS’ world-class imaging with ATEC’s procedural know-how will establish a distinct foundation upon which ATEC Informed by EOS™ can provide surgeons with what they desire most: actionable information that can be reconciled with the preoperative plan. EOS-informed surgeries can better achieve alignment objectives and there is no greater predictor of successful, long-term clinical outcomes than spinal alignment. Together, as the company that improves patient lives by best informing spine surgery, we will be the Standard Bearer in Spine.”
Combining ATEC with EOS, the recognized global leader in full-body, 2D/3D spine imaging solutions, will create new treatment standards in spine through:
“The prevalence of EOS’ technology in academic institutions worldwide is a clear indication of its profound clinical value,” said Christopher Shaffrey, MD, Chief of the Spine Division at Duke Neurosurgery and Orthopedic Surgery. “In my practice, EOS’ full body imaging and 3D modeling capabilities facilitate improved assessments of spinal deformities and functional alignment, significantly upgrading patient care. I’m thrilled that ATEC has embraced EOS’ unique technology. As the company most committed to perpetual innovation in spine, ATEC is best-equipped to extend EOS’ functionality to truly advance spine surgery with better information.”
About ATEC
ATEC, through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging and SafeOp Surgical, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction. ATEC’s Organic Innovation Machine™ is focused on developing new approaches that integrate seamlessly with the Company’s expanding AlphaInformatiX Platform to better inform surgery and more safely and reproducibly achieve the goals of spine surgery. ATEC’s vision is to become the Standard Bearer in Spine. For more information, visit us at www.atecspine.com.
Forward Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management’s current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The Company cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors. Forward-looking statements include, but are not limited to, references to the Company’s expectations with respect to revenue and growth and the benefits and synergies of the acquisition of EOS imaging, S.A. Important factors that could cause actual results to differ from those expressed or implied by such forward-looking statements include, but are not limited to: failure to achieve acceptance by the surgeon community; continuation of favorable reimbursement for the Company’s products; product liability and patent infringement claims; uncertainties and risks related to the acquisition of EOS imaging, S.A.; and the impact of COVID-19. The words “believe,” “will,” “should,” “expect,” “intend,” “estimate,” “look forward” and “anticipate,” variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. A further list and description of these and other factors, risks and uncertainties can be found in the Company’s most recent annual report, and any subsequent quarterly and current reports, filed with the Securities and Exchange Commission. ATEC disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law.
Investor/Media Contact:
Tina Jacobsen, CFA
Investor Relations
(760) 494-6790
investorrelations@atecspine.com
Company Contact:
J. Todd Koning
Chief Financial Officer
investorrelations@atecspine.com
The publication includes a subset of data from the ACTION PMR stroke study and provides…
IRVINE, Calif.--(BUSINESS WIRE)--To ensure that Politan lies repeated over and over are not taken as…
WAYNE, NJ / ACCESSWIRE / July 15, 2024 / Complete Care Lakeview, a leading provider…
Pre-clinical study to explore use of MODD1 pump as a delivery system for FDA-approved, short…
Testing confirms MIRA's preliminary beliefs regarding potential treatment for neurological and neuropsychiatric disorders MIAMI, FL…
ORLANDO, FL / ACCESSWIRE / July 15, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of…